Section Arrow
Quote
LMAT.NASDAQ
- LeMaitre Vascular
Quotes are at least 15-min delayed:2026/11/05 11:14 EST
Regular Hours
Last
 82.635
-5.285 (-6.01%)
Day High 
85.97 
Prev. Close
87.92 
1-M High
89.23 
Volume 
183.81K 
Bid
81.94
Ask
83.32
Day Low
81.79 
Open
81.79 
1-M Low
78.31 
Market Cap 
2.01B 
Currency 美元 
P/E 30.74 
%Yield 1.14 
10-SMA 83.67 
20-SMA 82.88 
50-SMA 81.38 
52-W High 118.01 
52-W Low 78.22 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.86/3.15
Enterprise Value
2.19B
Balance Sheet
Book Value Per Share
18.38
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
249.60M
Operating Revenue Per Share
8.11
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
WRBYWarby Parker25.805+4.515+21.21%354.83PE
MDLNMedline Inc40.22-0.13-0.32%50.48PE
NVSTEnvista Holdings Corp24.835-2.355-8.66%46.88PE
BAXBaxter International25.785-0.715-2.70%-- 
MMEDMiniMed Group, Inc.18.66-0.63-3.27%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded productsused in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.